Australia Clinical Trial Supply & Logistics Market Size & Outlook
The clinical trial supply & logistics market in Australia is expected to reach a projected revenue of US$ 138.5 million by 2030. A compound annual growth rate of 7.9% is expected of Australia clinical trial supply & logistics market from 2024 to 2030.
Australia clinical trial supply & logistics market highlights
The Australia clinical trial supply & logistics market generated a revenue of USD 81.5 million in 2023 and is expected to reach USD 138.5 million by 2030.
The Australia market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
In terms of segment, logistics & distribution was the largest revenue generating service in 2023.
Logistics & distribution is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial supply & logistics market data book summary
Market revenue in 2023
USD 81.5 million
Market revenue in 2030
USD 138.5 million
Growth rate
7.9% (CAGR from 2023 to 2030)
Largest segment
Logistics & distribution
Fastest growing segment
Logistics & distribution
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply)
In terms of revenue, Australia accounted for 2.2% of the global clinical trial supply & logistics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China clinical trial supply & logistics market is projected to lead the regional market in terms of revenue in 2030.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 281.1 million by 2030.
The country is one of the fastest growing countries in terms of conducting clinical trials. Around 8,180 clinical trial research were registered in the U.S. clinical trial database by June 2021 (with Australian sites involved).
With a population of around 25 million individuals, the country has a high number of high-quality clinical sites, which allows fast enrollment in clinical studies. Main cities in Australia centralizing clinical trials include Melbourne, Sydney, and Brisbane.
Furthermore, growing government support is anticipated to attract biopharmaceutical companies to conduct trials and promote entry of clinical trial supply and logistics players. These factors are expected to contribute to growth of Australia clinical trial supply and logistics market.
Australia Clinical Trial Supply & Logistics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Trial Supply & Logistics Market Outlook will help companies and investors design strategic landscapes.
Logistics & Distribution was the largest segment with a revenue share of 25.4% in 2023.
Horizon Databook has segmented the Australia clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
The country is one of the fastest growing countries in terms of conducting clinical trials. Around 8,180 clinical trial research were registered in the U.S. clinical trial database by June 2021 (with Australian sites involved).
With a population of around 25 million individuals, the country has a high number of high-quality clinical sites, which allows fast enrollment in clinical studies. Main cities in Australia centralizing clinical trials include Melbourne, Sydney, and Brisbane.
Furthermore, growing government support is anticipated to attract biopharmaceutical companies to conduct trials and promote entry of clinical trial supply and logistics players. These factors are expected to contribute to growth of Australia clinical trial supply and logistics market.
Australia Clinical Trial Supply & Logistics Market Service Outlook (Revenue, USD Million , 2018-2030)
Logistics & distribution
Storage & retention
Packaging, labeling and blinding
Manufacturing
Comparator sourcing
Other services (solutions, ancillary supply)
Australia Clinical Trial Supply & Logistics Market End User Outlook (Revenue, USD Million , 2018-2030)
Pharmaceuticals
Biologicals
Medical Device
Australia Clinical Trial Supply & Logistics Market Therapeutic Areas Outlook (Revenue, USD Million , 2018-2030)
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
Australia Clinical Trial Supply & Logistics Market Phase Outlook (Revenue, USD Million , 2018-2030)
Phase I
Phase II
Phase III
Phase IV
Reasons to subscribe to Clinical Trial Supply & Logistics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Trial Supply & Logistics Market Outlook databook
Our clientele includes a mix of Clinical Trial Supply & Logistics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Clinical Trial Supply & Logistics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Clinical Trial Supply & Logistics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia Clinical Trial Supply Logistics Market, 2018-2030 (US$M)